IS5855A - Algínat hylki til notkunar við meðferð á heilaæxli - Google Patents

Algínat hylki til notkunar við meðferð á heilaæxli

Info

Publication number
IS5855A
IS5855A IS5855A IS5855A IS5855A IS 5855 A IS5855 A IS 5855A IS 5855 A IS5855 A IS 5855A IS 5855 A IS5855 A IS 5855A IS 5855 A IS5855 A IS 5855A
Authority
IS
Iceland
Prior art keywords
treatment
brain tumors
alginate capsules
alginate
capsules
Prior art date
Application number
IS5855A
Other languages
English (en)
Inventor
Bjerkvig Rolf
Original Assignee
Norsk Hydro Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro Asa filed Critical Norsk Hydro Asa
Publication of IS5855A publication Critical patent/IS5855A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5855A 1998-08-26 2001-02-22 Algínat hylki til notkunar við meðferð á heilaæxli IS5855A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO983911A NO983911D0 (no) 1998-08-26 1998-08-26 Alginatkapsler til bruk ved behandling av hjernesvulst
PCT/NO1999/000266 WO2000012066A1 (en) 1998-08-26 1999-08-25 Alginate capsules for use in the treatment of brain tumour

Publications (1)

Publication Number Publication Date
IS5855A true IS5855A (is) 2001-02-22

Family

ID=19902361

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5855A IS5855A (is) 1998-08-26 2001-02-22 Algínat hylki til notkunar við meðferð á heilaæxli

Country Status (16)

Country Link
US (2) US6926888B1 (is)
EP (1) EP1105100A1 (is)
JP (1) JP2002523445A (is)
KR (1) KR100699286B1 (is)
CN (1) CN1191823C (is)
AU (1) AU760433B2 (is)
BR (1) BR9913326A (is)
CA (1) CA2340325A1 (is)
IL (2) IL141501A0 (is)
IS (1) IS5855A (is)
NO (2) NO983911D0 (is)
NZ (1) NZ510167A (is)
RU (1) RU2229287C2 (is)
TR (1) TR200100583T2 (is)
WO (1) WO2000012066A1 (is)
ZA (1) ZA200101464B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1053329E (pt) * 1998-02-03 2010-01-04 Ct Disease Contr & Prevention Proteína psaa lipidada recombinante, métodos de preparação e utilização
SE530184C2 (sv) 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
RU2336901C1 (ru) * 2007-08-10 2008-10-27 Владимир Павлович Чехонин Противоопухолевое средство на основе иммунолипосомальной биологической конструкции, способ его получения и векторной доставки в центральную нервную систему при опухолевом процессе
KR100969516B1 (ko) * 2007-08-16 2010-07-09 경북대학교 산학협력단 세포 생존력 및 기능을 향상시키는 도우넛형 세포 캡슐의제조 방법 및 세포 치료적용
RU2422521C2 (ru) * 2009-07-31 2011-06-27 Федеральное государственное учреждение "48 Центральный научно-исследовательский институт Министерства обороны Российской Федерации" Способ получения гранул, содержащих иммобилизованные нефтеокисляющие микроорганизмы
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
UY38389A (es) * 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
CN118976106B (zh) * 2024-07-31 2025-12-09 湖南大学 一种藻酸盐基热遗传学cxcl12释放器及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006692A1 (en) * 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
US5073491A (en) * 1988-12-23 1991-12-17 Hoffman-La Roche Inc. Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors
US5459054A (en) * 1989-12-05 1995-10-17 Neocrin Company Cells encapsulated in alginate containing a high content of a- l- guluronic acid
US5166137A (en) 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
HK1001832A1 (en) * 1991-04-25 1998-07-10 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
AU699405B2 (en) 1994-07-08 1998-12-03 Baxter International Inc. Implanted device containing tumor cells for the treatment of cancer
US6126936A (en) * 1995-03-10 2000-10-03 Biohybrid Technologies Llc Microcapsules and composite microreactors for immunoisolation of cells
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
NZ331960A (en) 1996-04-03 1999-10-28 Rogosin Inst Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
WO1997038707A1 (en) * 1996-04-17 1997-10-23 Cytotherapeutics, Inc. Method and device for delivery of apoptosis-inducing molecules
US6027721A (en) 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
DE19638745C2 (de) * 1996-09-11 2001-05-10 Schering Ag Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR)
US6368612B1 (en) * 1997-12-12 2002-04-09 Biohybrid Technologies Llc Devices for cloaking transplanted cells

Also Published As

Publication number Publication date
US20050180960A1 (en) 2005-08-18
CN1320032A (zh) 2001-10-31
KR100699286B1 (ko) 2007-03-26
JP2002523445A (ja) 2002-07-30
IL141501A0 (en) 2002-03-10
TR200100583T2 (tr) 2001-06-21
NZ510167A (en) 2003-09-26
AU760433B2 (en) 2003-05-15
KR20010074851A (ko) 2001-08-09
NO20010960L (no) 2001-04-25
CA2340325A1 (en) 2000-03-09
NO20010960D0 (no) 2001-02-26
RU2229287C2 (ru) 2004-05-27
ZA200101464B (en) 2002-05-21
BR9913326A (pt) 2001-05-15
IL141501A (en) 2006-10-31
CN1191823C (zh) 2005-03-09
WO2000012066A1 (en) 2000-03-09
AU5538999A (en) 2000-03-21
US6926888B1 (en) 2005-08-09
NO983911D0 (no) 1998-08-26
EP1105100A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
IS6303A (is) Notkun retígabíns til meðhöndlunar á taugasjúkdómatengdum sársauka
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DE59913141D1 (de) Blutbehandlungsgerät
DE69825447D1 (de) Gerät zur dermatologischen behandlung
FI20000863A0 (fi) Uusi hoitomenetelmä
NO20014769L (no) Preparat for behandling og diagnostikk av brystcancer og fremgangsmater for anvendelse derav
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
IS4274A (is) Imidasópýridínsambönd til að nota við meðhöndlun sjúkdóma í meltingarvegi
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
IS5855A (is) Algínat hylki til notkunar við meðferð á heilaæxli
HUP0101947A3 (en) Combination for the treatment of tumors
PT1051172E (pt) Metodo para tratamento da dpco
GB0025101D0 (en) Fluid treatment apparatus
IS5481A (is) Samsett meðferð til meðhöndlunar á alnæmi
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
NO20012616D0 (no) Middel til behandling av erektil malfunksjon
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
GB2341099B (en) Clinical table for treatment of the spine